Search

Hilton A Salhanick

from Brookline, MA
Deceased
Get Report
Also known as:
Hilton Dr Salhanick
Phone and address:
87 Colchester St, Brookline, MA 02446
Related to:
Evan SalhanickBeverly Joan Salhanick, 66Catherine O SalhanickSteven Salhanick, 61
Connected to:
Joan E Salhany, 70Richard C Salhany, 61Klaus Salheiser, 74Deborah L Salher, 70Abderrahim M Salhi, 55Kamal Salhi, 42Rami Salhi, 34Samer M Salhi, 53Kevin P Salhoff, 45Mohammed M Salhoot, 82

Hilton Salhanick Phones & Addresses

  • 87 Colchester St, Brookline, MA 02446
  • Mount Vernon, ME
  • Andover, MA
  • 1 Rachel Rd, Andover, MA 01810

Work

Company: None Position: None

Industries

Research

Professional Records

License Records

Hilton Aaron Salhanick Md

License #:
10208 - Expired
Category:
Medicine
Issued Date:
Sep 15, 1958
Effective Date:
Oct 1, 1988
Type:
Physician

Resumes

Resumes

Hilton Salhanick Photo 1

None At None

View page
Position:
none at none
Location:
Greater Boston Area
Industry:
Research
Work:
none
none

Business Records

Name / Title
Company / Classification
Phones & Addresses
Hilton Salhanick
President
BIODIAGNOSTICS, INC
87 Colchester St, Cambridge, MA 02139
87 Colchester St, Brookline, MA 02146

Publications

Us Patents

Directed Metabolism Of Compounds By Glucuronidation And Sulfonation Donors To Decrease Toxicity

View page
US Patent:
20080188439, Aug 7, 2008
Filed:
Oct 26, 2007
Appl. No.:
11/977809
Inventors:
Steven D. Salhanick - Andover MA, US
Hilton A. Salhanick - Brookline MA, US
International Classification:
A61K 31/7076
A61K 31/7072
A61P 1/16
US Classification:
514 47, 514 51
Abstract:
Disclosed are compositions and methods of treatment with uridine-based and phosphoadenosine-based cofactors for the prevention and treatment of toxicity associated with compounds such as acetaminophen, which undergo Phase II glucuronidation and sulfonation in the liver. Uridine diphosphoglucose, phosphoadenosine-phosphosulfate, and their derivatives can be administered exogenously either to prevent their depletion in the liver during treatment with acetaminophen, or to replace depleted substrates of UDPGA-transferase or PAPS-transferase in order to treat an individual after a toxic dose of acetaminophen has been ingested.

Methods For Diagnosing Thyroid Conditions And For Monitoring Thyroxine Therapy

View page
US Patent:
20020076827, Jun 20, 2002
Filed:
Jul 26, 2001
Appl. No.:
09/915931
Inventors:
Hilton Salhanick - Brookline MA, US
Joachim Hourihan - Dorchester MA, US
International Classification:
G01N033/566
G01N033/543
US Classification:
436/501000
Abstract:
This invention provides a method of diagnosing a thyroid condition in a subject which comprises: determining the concentration of thyroid stimulating hormone in a urine sample by a method which is not a radioimmunoassay; and comparing the concentration of thyroid stimulating hormone with a urinary concentration of thyroid stimulating hormone in a normal subject; wherein: i) a concentration of thyroid stimulating hormone which is higher than the urinary concentration of thyroid stimulating hormone in the normal subject diagnoses hypothyroidism in the subject; and ii) a concentration of thyroid stimulating hormone which is lower than the urinary concentration of thyroid stimulating hormone in the normal subject diagnoses hyperthyroidism in the subject. This invention also proves a method of monitoring thyroxine therapy.
Control profile
Hilton A Salhanick from Brookline, MADeceased Get Report